位置:首页 > 蛋白库 > OTOP1_MOUSE
OTOP1_MOUSE
ID   OTOP1_MOUSE             Reviewed;         600 AA.
AC   Q80VM9; A0A0R4J1J4; E9QMU2; Q7M735; Q8BRZ4; Q8BS22;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 3.
DT   03-AUG-2022, entry version 103.
DE   RecName: Full=Proton channel OTOP1 {ECO:0000305};
DE   AltName: Full=Otopetrin-1 {ECO:0000303|PubMed:12651873};
GN   Name=Otop1 {ECO:0000303|PubMed:12651873, ECO:0000312|MGI:MGI:2388363};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), FUNCTION, DISRUPTION
RP   PHENOTYPE, TISSUE SPECIFICITY, AND MUTAGENESIS OF ALA-151 AND LEU-408.
RC   STRAIN=C57BL/6J; TISSUE=Otocyst;
RX   PubMed=12651873; DOI=10.1093/hmg/ddg087;
RA   Hurle B., Ignatova E., Massironi S.M., Mashimo T., Rios X., Thalmann I.,
RA   Thalmann R., Ornitz D.M.;
RT   "Non-syndromic vestibular disorder with otoconial agenesis in
RT   tilted/mergulhador mice caused by mutations in otopetrin 1.";
RL   Hum. Mol. Genet. 12:777-789(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Aorta, and Vein;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   FUNCTION.
RX   PubMed=17606897; DOI=10.1073/pnas.0705182104;
RA   Hughes I., Saito M., Schlesinger P.H., Ornitz D.M.;
RT   "Otopetrin 1 activation by purinergic nucleotides regulates intracellular
RT   calcium.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:12023-12028(2007).
RN   [5]
RP   FUNCTION.
RX   PubMed=20554841; DOI=10.1152/jn.00525.2010;
RA   Kim E., Hyrc K.L., Speck J., Lundberg Y.W., Salles F.T., Kachar B.,
RA   Goldberg M.P., Warchol M.E., Ornitz D.M.;
RT   "Regulation of cellular calcium in vestibular supporting cells by otopetrin
RT   1.";
RL   J. Neurophysiol. 104:3439-3450(2010).
RN   [6]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF ALA-151 AND LEU-408.
RX   PubMed=21236346; DOI=10.1016/j.mcn.2011.01.005;
RA   Kim E., Hyrc K.L., Speck J., Salles F.T., Lundberg Y.W., Goldberg M.P.,
RA   Kachar B., Warchol M.E., Ornitz D.M.;
RT   "Missense mutations in Otopetrin 1 affect subcellular localization and
RT   inhibition of purinergic signaling in vestibular supporting cells.";
RL   Mol. Cell. Neurosci. 46:655-661(2011).
RN   [7]
RP   FUNCTION, DISRUPTION PHENOTYPE, INDUCTION, AND INTERACTION WITH STAT1.
RX   PubMed=24379350; DOI=10.2337/db13-1139;
RA   Wang G.X., Cho K.W., Uhm M., Hu C.R., Li S., Cozacov Z., Xu A.E.,
RA   Cheng J.X., Saltiel A.R., Lumeng C.N., Lin J.D.;
RT   "Otopetrin 1 protects mice from obesity-associated metabolic dysfunction
RT   through attenuating adipose tissue inflammation.";
RL   Diabetes 63:1340-1352(2014).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   ALA-151.
RX   PubMed=29371428; DOI=10.1126/science.aao3264;
RA   Tu Y.H., Cooper A.J., Teng B., Chang R.B., Artiga D.J., Turner H.N.,
RA   Mulhall E.M., Ye W., Smith A.D., Liman E.R.;
RT   "An evolutionarily conserved gene family encodes proton-selective ion
RT   channels.";
RL   Science 359:1047-1050(2018).
CC   -!- FUNCTION: Proton-selective channel that specifically transports protons
CC       into cells (PubMed:29371428). Proton channel activity is only weakly-
CC       sensitive to voltage (PubMed:29371428). Proton-selective channel
CC       activity is probably required in cell types that use changes in
CC       intracellular pH for cell signaling or to regulate biochemical or
CC       developmental processes (PubMed:29371428). In the vestibular system of
CC       the inner ear, required for the formation and function of otoconia,
CC       which are calcium carbonate crystals that sense gravity and
CC       acceleration (PubMed:12651873). Probably acts by maintaining the pH
CC       appropriate for formation of otoconia (PubMed:29371428). Regulates
CC       purinergic control of intracellular calcium in vestibular supporting
CC       cells (PubMed:17606897, PubMed:20554841). May be involved in sour taste
CC       perception in sour taste cells by mediating entry of protons within the
CC       cytosol (PubMed:29371428). Also involved in energy metabolism, by
CC       reducing adipose tissue inflammation and protecting from obesity-
CC       induced metabolic dysfunction (PubMed:24379350).
CC       {ECO:0000269|PubMed:12651873, ECO:0000269|PubMed:17606897,
CC       ECO:0000269|PubMed:20554841, ECO:0000269|PubMed:24379350,
CC       ECO:0000269|PubMed:29371428}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:29371428};
CC       Multi-pass membrane protein {ECO:0000255}. Note=Detected in the
CC       gelatinous membrane overlying the inner ear macular epithelium.
CC       {ECO:0000269|PubMed:12651873, ECO:0000269|PubMed:21236346}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=A, Otopetrin-1a, Otop1-a;
CC         IsoId=Q80VM9-1; Sequence=Displayed;
CC       Name=2; Synonyms=C, Otopetrin-1c, Otop1-c;
CC         IsoId=Q80VM9-2; Sequence=VSP_030160;
CC       Name=3; Synonyms=B, Otopetrin-1b, Otop1-b;
CC         IsoId=Q80VM9-3; Sequence=VSP_030161;
CC   -!- TISSUE SPECIFICITY: Detected in embryonic inner ear macular epithelia
CC       (PubMed:12651873). Expressed in thymus, heart, kidney, skin, vestibular
CC       system of the inner ear, sour taste cells, brown adipose tissue, heart,
CC       uterus, dorsal root ganglion, adrenal gland, lactating mammary gland
CC       and stimulated mast cells (PubMed:12651873, PubMed:29371428).
CC       Specifically expressed in sour taste cells and not other types of taste
CC       cells (PubMed:29371428). {ECO:0000269|PubMed:12651873,
CC       ECO:0000269|PubMed:29371428}.
CC   -!- INDUCTION: Up-regulated in white adipose tissue in response to pro-
CC       inflammatory signaling. {ECO:0000269|PubMed:24379350}.
CC   -!- DISRUPTION PHENOTYPE: Mice display defects in the formation of otoconia
CC       in the inner ear, but do not suffer from deafness or other inner ear
CC       defects (PubMed:12651873). They cannot perceive gravity and have
CC       problems with spatial orientation and with keeping their equilibrium
CC       (PubMed:12651873). They show typical head-tilting behavior and are
CC       unable to swim (PubMed:12651873). Mice develop more severe diet-induced
CC       metabolic disorders: they respond to high-fat diet with pronounced
CC       insulin resistance and hepatic steatosis, accompanied by augmented
CC       adipose tissue inflammation (PubMed:24379350).
CC       {ECO:0000269|PubMed:12651873, ECO:0000269|PubMed:24379350}.
CC   -!- SIMILARITY: Belongs to the otopetrin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Ear of stone - Issue 89 of
CC       December 2007;
CC       URL="https://web.expasy.org/spotlight/back_issues/089";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF548337; AAO33824.1; -; mRNA.
DR   EMBL; BK000650; DAA00897.1; -; Genomic_DNA.
DR   EMBL; BK000650; DAA00898.1; -; Genomic_DNA.
DR   EMBL; AK040792; BAC30704.1; -; mRNA.
DR   EMBL; AK041023; BAC30785.1; -; mRNA.
DR   EMBL; AC084071; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_766297.2; NM_172709.3. [Q80VM9-1]
DR   AlphaFoldDB; Q80VM9; -.
DR   SMR; Q80VM9; -.
DR   STRING; 10090.ENSMUSP00000109734; -.
DR   TCDB; 1.A.110.1.1; the channel-forming otopetrin (otop) family.
DR   iPTMnet; Q80VM9; -.
DR   PhosphoSitePlus; Q80VM9; -.
DR   PaxDb; Q80VM9; -.
DR   PRIDE; Q80VM9; -.
DR   ProteomicsDB; 295486; -. [Q80VM9-1]
DR   ProteomicsDB; 372053; -.
DR   Antibodypedia; 22553; 83 antibodies from 20 providers.
DR   DNASU; 21906; -.
DR   Ensembl; ENSMUST00000114099; ENSMUSP00000109734; ENSMUSG00000051596. [Q80VM9-1]
DR   GeneID; 21906; -.
DR   KEGG; mmu:21906; -.
DR   UCSC; uc008xgm.1; mouse. [Q80VM9-1]
DR   UCSC; uc012dvn.1; mouse.
DR   CTD; 133060; -.
DR   MGI; MGI:2388363; Otop1.
DR   VEuPathDB; HostDB:ENSMUSG00000051596; -.
DR   eggNOG; KOG4740; Eukaryota.
DR   GeneTree; ENSGT00940000159350; -.
DR   InParanoid; Q80VM9; -.
DR   OMA; HPRYTWY; -.
DR   OrthoDB; 524642at2759; -.
DR   PhylomeDB; Q80VM9; -.
DR   TreeFam; TF313428; -.
DR   BioGRID-ORCS; 21906; 1 hit in 33 CRISPR screens.
DR   PRO; PR:Q80VM9; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   RNAct; Q80VM9; protein.
DR   Bgee; ENSMUSG00000051596; Expressed in otolith organ and 46 other tissues.
DR   ExpressionAtlas; Q80VM9; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015252; F:proton channel activity; IDA:UniProtKB.
DR   GO; GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IMP:UniProtKB.
DR   GO; GO:0009590; P:detection of gravity; IMP:MGI.
DR   GO; GO:0042472; P:inner ear morphogenesis; IMP:MGI.
DR   GO; GO:0060336; P:negative regulation of interferon-gamma-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:1902600; P:proton transmembrane transport; IDA:UniProtKB.
DR   InterPro; IPR004878; Otopetrin.
DR   PANTHER; PTHR21522; PTHR21522; 1.
DR   Pfam; PF03189; Otopetrin; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Biomineralization; Cell membrane;
KW   Hydrogen ion transport; Ion channel; Ion transport; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..600
FT                   /note="Proton channel OTOP1"
FT                   /id="PRO_0000313817"
FT   TRANSMEM        65..85
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        90..110
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        135..155
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        166..186
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        199..219
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        267..287
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        309..329
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        345..365
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        391..411
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        422..442
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        533..553
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        564..584
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..190
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_030160"
FT   VAR_SEQ         1..35
FT                   /note="MPGGPGAPSSPAASSGSSRAAPSGIAACPLSPPPL -> MLTPPETLSAFLA
FT                   GGFLGCLCLLEGLGCLRIA (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12651873"
FT                   /id="VSP_030161"
FT   MUTAGEN         151
FT                   /note="A->E: In tlt (tilted phenotype); affected mice have
FT                   defects in the formation of otoconia in the inner ear, but
FT                   do not suffer from deafness or other inner ear defects.
FT                   They cannot perceive gravity and have problems with spatial
FT                   orientation and with keeping their equilibrium. They show
FT                   typical head-tilting behavior and are unable to swim.
FT                   Impaired subcellular localization to the plasma membrane.
FT                   Effects may be due to dysregulation of pH."
FT                   /evidence="ECO:0000269|PubMed:12651873,
FT                   ECO:0000269|PubMed:21236346, ECO:0000269|PubMed:29371428"
FT   MUTAGEN         408
FT                   /note="L->Q: In mlh (mergulhador phenotype); affected mice
FT                   have defects in the formation of otoconia in the inner ear,
FT                   but do not suffer from deafness or other inner ear defects.
FT                   They cannot perceive gravity and have problems with spatial
FT                   orientation and with keeping their equilibrium. They show
FT                   typical head-tilting behavior and are unable to swim.
FT                   Impaired subcellular localization to the plasma membrane."
FT                   /evidence="ECO:0000269|PubMed:12651873,
FT                   ECO:0000269|PubMed:21236346"
FT   CONFLICT        396
FT                   /note="G -> A (in Ref. 2; BAC30704/BAC30785)"
FT   CONFLICT        401
FT                   /note="L -> P (in Ref. 2; BAC30704)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   600 AA;  65755 MW;  CC10FA749803064B CRC64;
     MPGGPGAPSS PAASSGSSRA APSGIAACPL SPPPLARGSP QASGPRRGAS VPQKLAETLS
     SQYGLNVFVA GLLFLLAWAV HATGVGKSDL LCVLTALMLL QLLWMLWYVG RSYMQRRLIR
     PKDTHAGARW LRGSITLFAF ITVVLGCLKV AYFIGFSECL SATEGVFPVT HAVHTLLQVY
     FLWGHAKDII MSFKTLERFG VIHSVFTNLL LWANSVLNES KHQLNEHKER LITLGFGNIT
     IVLDDHTPQC NCTPPALCSA LSHGIYYLYP FNIEYQILAS TMLYVLWKNI GRRVDSSQHQ
     KMQCRFDGVL VGSVLGLTVL AATIAVVVVY MIHIGRSKSK SESALIMFYL YAITVLLLMG
     AAGLVGSWIY RVDEKSLDES KNPARKLDVD LLVATGSGSW LLSWGSILAI ACAETRPPYT
     WYNLPYSVLV IVEKYVQNIF IIESVHLEPE GVPEDVRTLR VVTVCSSEAA ALAASTLGSQ
     GMAQDGSPAV NGNLCLQQRC GKEDQESGWE GATGTTRCLD FLQGGMKRRL LRNITAFLFL
     CNISLWIPPA FGCRPEYDNG LEEIVFGFEP WIIVVNLAMP FSIFYRMHAA AALFEVYCKI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024